Search results
Results from the WOW.Com Content Network
Nike, Inc.[ note 1 ] (stylized as NIKE) is an American athletic footwear and apparel corporation headquartered near Beaverton, Oregon, United States. [ 5 ] It is the world's largest supplier of athletic shoes and apparel and a major manufacturer of sports equipment, with revenue in excess of US$46 billion in its fiscal year 2022. [ 6 ][ 7 ]
The Nike Sport Research Lab is a research and development institute located in Beaverton in the U.S. state of Oregon. Opened in 1980, the lab is owned by American apparel and footwear maker Nike. [1] Commercials for the facility have featured famous NBA and PGA athletes talking positively about the products and the research behind them.
In 2012, Jones became Vice President of Sustainable Business & Innovation, where she stewarded the Nike, Inc. sustainability strategy and led a team that innovated business models and leveraged transparency and collaborations in search of sustainable solutions. In April 2014, she was promoted to Chief Sustainability Officer and Vice President ...
Puma ranks as one of the top shoe brands with Adidas and Nike, [6] and employs more than 18,000 people worldwide. [3] The company has corporate offices around the world, including four defined as "central hubs": Assembly Row, Somerville, Massachusetts; [46] Hong Kong; Ho Chi Minh City, Vietnam; and global headquarters in Herzogenaurach, Germany.
Nike is a business known around the world, but is it a smart investment? Read on to learn more about the company's worth and if you should consider investing.
Coexistence theory is a framework to understand how competitor traits can maintain species diversity and stave-off competitive exclusion even among similar species living in ecologically similar environments. Coexistence theory explains the stable coexistence of species as an interaction between two opposing forces: fitness differences between ...
John Joseph Donahoe II (born April 30, 1960) [1] is an American businessman who is the CEO of Nike from January 2020, until his upcoming exit in October 2024. [2] Early in his career, he worked for Bain & Company, becoming the firm's president and CEO in 1999. [3] He is on the board of directors at Nike, [4] The Bridgespan Group [5] and is ...
Meldonium (INN; trade name Mildronate, among others) is a limited-market pharmaceutical, developed in 1970 by Ivars KalviĊš at the USSR Latvia Institute of Organic Synthesis, and now manufactured by the Latvian pharmaceutical company Grindeks and several generic manufacturers.